Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03520517 |
|
Recruitment Status :
Completed
First Posted : May 9, 2018
Last Update Posted : October 6, 2022
|
Sponsor:
Biohaven Pharmaceuticals, Inc.
Collaborator:
Cognitive Research Corporation
Information provided by (Responsible Party):
Biohaven Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 8, 2018 |
| Actual Study Completion Date : | October 8, 2018 |